Additional file 1 of Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide

Toulmonde, Maud; Guegan, Jean-Philippe; Spalato-Ceruso, Mariella; Peyraud, Florent; Kind, Michèle; Vanhersecke, Lucile; Le Loarer, François; Perret, Raul; Cantarel, Coralie; Bellera, Carine; Bessede, Alban; Italiano, Antoine

doi:10.6084/m9.figshare.25255854.v1

12943_2024_1946_MOESM1_ESM.docx (383.88 kB)

Additional file 1 of Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide

journal contribution

posted on 2024-02-21, 04:40 authored by Maud Toulmonde, Jean-Philippe Guegan, Mariella Spalato-Ceruso, Florent Peyraud, Michèle Kind, Lucile Vanhersecke, François Le Loarer, Raul Perret, Coralie Cantarel, Carine Bellera, Alban Bessede, Antoine Italiano

Supplementary Material 1

Funding

Agence Nationale de la Recherche

History

Usage metrics

Keywords

Soft-tissue sarcoma Oncolytic virus JX-594 Low-dose cyclophosphamide Avelumab

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamide

Funding

Agence Nationale de la Recherche

History

Usage metrics

Categories

Keywords

Licence

Exports